BOCK, Mark G.,CHIKKANNA, Dinesh,MCCARTHY, Clive,MOEBITZ, Henrik,PANDIT, Chetan,PODDUTOORI, Ramulu
申请号：
TN2012000242
公开号：
TN2012000242A1
申请日:
2012.05.21
申请国别(地区):
TN
年份:
2013
代理人:
摘要：
The present invention relates to compounds of formula (I) and pharmaceutically acceptable salts thereof. The compounds have been demonstrated as inhibitors of MEK and therefore may be useful in the treatment of hyperproliferative diseases (e.g., cancer and inflammation).
